{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:44:19Z","timestamp":1764175459139},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The electronic prescription refill rate (EPRR) of 183 consecutive patients was determined over a 19-month retrospective study period, divided into 7\u00a0months PRE (Sep-19 to Mar-20) and 12\u00a0months POST pandemic (Apr-20 to Mar-21), in order to compare adherence to inhaled corticosteroids (ICS) in patients with asthma prior to and during the COVID-19 pandemic. Before the pandemic (PRE), an average of 0.58 inhalers\/month were refill from the pharmacy; [SD 0.33], very similar to the 0.59 inhalers\/month; [SD 0.34] retrieved during the 12 subsequent months since the pandemic (POST) (p\u2009=\u20090.768). EPRR showed no differences (p\u2009=\u20090.784). When EPRR was dichotomous or ordinal categorised no differences were found either (p\u2009=\u20090.851 and 0.928), even when McNemar's test was used (p\u2009=\u20090.949), with prevalences of nonadherence (EPRR\u2009&lt;\u200980%) of 57 and 58% respectively. Our results do not support increased adherence to inhaler treatment in terms of EPRR, comparing before and since COVID-19 pandemic. Compliance with prescription remains suboptimal.<\/jats:p>","DOI":"10.1038\/s41598-023-40213-6","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T15:02:28Z","timestamp":1691766148000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Adherence to inhaled corticosteroids in patients with asthma prior to and during the COVID-19 pandemic"],"prefix":"10.1038","volume":"13","author":[{"given":"Isabel","family":"Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"L\u00f3pez-Caro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Gonzalez-Carranza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Elena","family":"Cerrato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Mar","family":"De Prado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Gomez-Molleda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Pinel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Saiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Barreiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Santib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"40213_CR1","first-page":"47","volume-title":"Adherence to Long-Term Therapies: Evidence for Action","author":"B Bender","year":"2003","unstructured":"Bender, B. et al. Asthma. In Adherence to Long-Term Therapies: Evidence for Action (ed. Sabate, E.) 47\u201358 (World Health Organization, 2003)."},{"key":"40213_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3109\/02770900903497204","volume":"47","author":"A Bozek","year":"2010","unstructured":"Bozek, A. & Jarzab, J. Adherence to asthma therapy in elderly patients. J. Asthma. 47, 162\u2013165 (2010).","journal-title":"J. Asthma."},{"key":"40213_CR3","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1080\/02770903.2018.1426769","volume":"55","author":"LP De LLano","year":"2018","unstructured":"De LLano, L. P. et al. Assessing adherence to inhaled medication in asthma: Impact of once-daily versus twice-daily dosing frequency. The ATAUD study. J. Asthma. 55, 933\u2013938 (2018).","journal-title":"J. Asthma."},{"key":"40213_CR4","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1136\/thx.50.12.1274","volume":"50","author":"NA Gibson","year":"1995","unstructured":"Gibson, N. A., Ferguson, A. E., Aitchison, T. C. & Paton, J. Y. Compliance with inhaled asthma medication in preschool children. Thorax 50, 1274\u20131279 (1995).","journal-title":"Thorax"},{"issue":"2","key":"40213_CR5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1089\/jamp.2015.1212","volume":"29","author":"V Plaza","year":"2016","unstructured":"Plaza, V. et al. Validation of the \u2018Test of the Adherence to Inhalers\u2019 (TAI) for asthma and COPD patients. J. Aerosol. Med. Pulm. Drug Deliv. 29(2), 142\u2013152 (2016).","journal-title":"J. Aerosol. Med. Pulm. Drug Deliv."},{"issue":"7","key":"40213_CR6","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.arbres.2016.08.006","volume":"53","author":"V Plaza","year":"2017","unstructured":"Plaza, V., L\u00f3pez-Vi\u00f1a, A., Cosio, B. G., en representaci\u00f3n del Comit\u00e9 Cient\u00edfico del Proyecto TAI. Test of adherence to inhalers. Arch. Bronconeumol. 53(7), 360\u2013361 (2017) (English, Spanish).","journal-title":"Arch. Bronconeumol."},{"issue":"1","key":"40213_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.18176\/jiaci.0461","volume":"31","author":"V Plaza","year":"2021","unstructured":"Plaza, V. et al. Assessing adherence by combining the test of adherence to inhalers with pharmacy refill records. J. Investig. Allergol. Clin. Immunol. 31(1), 58\u201364 (2021).","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"40213_CR8","unstructured":"Spanish guideline for asthma management (GEMA) 5.2. https:\/\/drive.google.com\/file\/d\/1dbh_zh-V_aSVm_0bl1Gco0lSQ4w9j1xn\/view."},{"key":"40213_CR9","unstructured":"Spanish Ministry of Health. Secretary General for Health and Consumer Affairs. Directorate General for Public Health, Quality and Innovation. Informaci\u00f3n cient\u00edfica-t\u00e9cnica. Enfermedad por coronavirus, COVID-19 [Scientific and Technical Information, Coronavirus disease, COVID-19]. 26 March 2020 update. (version 2). Spanish. https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/nCov-China\/documentos\/20200326_ITCoronavirus.pdf (accessed 30 Mar 2020)."},{"key":"40213_CR10","unstructured":"World Health Organization (WHO). Coronavirus disease (COVID-2019) situation report-30. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200219-sitrep-30-covid-19 (accessed 30 Mar 2020)."},{"key":"40213_CR11","doi-asserted-by":"crossref","unstructured":"European Centre for Disease Prevention and Control (ECDC). Coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU\/EEA and the UK\u2014seventh update, 25 March 2020. Stockholm: ECDC; 2020. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/RRA-seventh-update-Outbreak-of-coronavirus-disease-COVID-19.pdf (accessed 30 Mar 2020).","DOI":"10.2807\/1560-7917.ES.2020.25.12.2003261"},{"key":"40213_CR12","unstructured":"COVID-19: Answers to Frequently Asked Questions on Asthma Management. [Internet] GINA; 2020. www.ginasthma.org\/covid-19-gina-answers-to-frequently-asked-ques-tions-on-asthma-management\/ (accessed 21 Apr 2020)."},{"key":"40213_CR13","unstructured":"Spanish Ministry of Health. Secretary General for Health and Consumer Affairs. Directorate General for Public Health, Quality and Innovation. Informaci\u00f3n cient\u00edfica-t\u00e9cnica. Enfermedad por coronavirus, COVID-19 [Scientific and Technical Information, Coronavirus disease, COVID-19]. 28 August 2020 update. Spanish. https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/nCov\/documentos\/ITCoronavirus.pdf (accessed 21 Oct 2020)."},{"key":"40213_CR14","unstructured":"European Centre for Disease Prevention and Control (ECDC). Coronavirus disease 2019 (COVID-19) pandemic: Increased transmission in the EU\/EEA and the UK\u2014twelfth update, 24 September 2020. Stockholm: ECDC; 2020. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/covid-19-risk-assessment-increased-transmission-twelfth-update (accessed 21 Oct 2020)."},{"key":"40213_CR15","unstructured":"Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). 2022. http:\/\/www.ginasthma.org."},{"key":"40213_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/02770903.2023.2209173","author":"E Fukutani","year":"2023","unstructured":"Fukutani, E. et al. Inhalation adherence for asthma and COPD improved during the COVID-19 pandemic: A questionnaire survey at a university hospital in Japan. J. Asthma. https:\/\/doi.org\/10.1080\/02770903.2023.2209173 (2023).","journal-title":"J. Asthma."},{"issue":"7","key":"40213_CR17","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1016\/j.jaip.2020.04.053","volume":"8","author":"L Kaye","year":"2020","unstructured":"Kaye, L. et al. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic. J. Allergy Clin. Immunol. Pract. 8(7), 2384\u20132385. https:\/\/doi.org\/10.1016\/j.jaip.2020.04.053 (2020) (Epub 2020 May 1. PMID: 32371047; PMCID: PMC7194036).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"1","key":"40213_CR18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jaip.2021.09.032","volume":"10","author":"H Dhruve","year":"2022","unstructured":"Dhruve, H. et al. Prescribing patterns and treatment adherence in patients with asthma during the COVID-19 pandemic. J. Allergy Clin. Immunol. Pract. 10(1), 100\u20131072. https:\/\/doi.org\/10.1016\/j.jaip.2021.09.032 (2022) (Epub 2021 Oct 2. PMID: 34610490; PMCID: PMC8487166).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"40213_CR19","unstructured":"Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). 2020. http:\/\/www.ginasthma.org."},{"key":"40213_CR20","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/j.1398-9995.2008.01877.x","volume":"64","author":"L Lasmar","year":"2009","unstructured":"Lasmar, L. et al. Adherence rate to inhaled corticosteroids and their impact on asthma control. Allergy 64, 784\u2013789 (2009).","journal-title":"Allergy"},{"key":"40213_CR21","unstructured":"Spanish guideline for asthma management (GEMA) 5.0. https:\/\/drive.google.com\/file\/d\/1r1RcVuKydAI3lnY2EiFZQVy1YCp1I9bs\/view."},{"key":"40213_CR22","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jaip.2016.07.007","volume":"4","author":"BG Bender","year":"2016","unstructured":"Bender, B. G. Non-adherence to asthma treatment: Getting unstuck. J. Allergy Clin. Immunol. Pract. 4, 849\u2013851 (2016).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"10","key":"40213_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.arbr.2019.01.014","volume":"55","author":"C Rodr\u00edguez-Garc\u00eda","year":"2019","unstructured":"Rodr\u00edguez-Garc\u00eda, C., Lourido-Cebreiro, T. & Gonz\u00e1lez-Barcala, F. J. The ATAUD study: The need to improve adherence. Arch. Bronconeumol. (Engl. Ed). 55(10), 509\u2013510 (2019) (English, Spanish).","journal-title":"Arch. Bronconeumol. (Engl. Ed)."},{"issue":"2","key":"40213_CR24","first-page":"135","volume":"32","author":"M Entrenas","year":"2020","unstructured":"Entrenas, M., Ramos, P. & Entrena, L. M. El test de adhesion a los inhaladores sobreestima el cumplimiento de la medicaci\u00f3n en el asma [Inhaler adherence test overestimates medication adherence in asthma]. Rev. Esp. Patol. Torac. 32(2), 135\u2013140 (2020) (Spanish).","journal-title":"Rev. Esp. Patol. Torac."},{"key":"40213_CR25","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jaip.2013.06.015","volume":"1","author":"AH Chan","year":"2013","unstructured":"Chan, A. H. et al. Adherence monitoring and ehealth: How clinicians and researchers can use technology to promote inhaler adherence for asthma. J. Allergy Clin. Immunol. Pract. 1, 446\u2013454 (2013).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"40213_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.105914","volume":"164","author":"HEH De Keyser","year":"2020","unstructured":"De Keyser, H. E. H. et al. Electronic medication monitors help determine adherence subgroups in asthma. Respir. Med. 164, 105914. https:\/\/doi.org\/10.1016\/j.rmed.2020.105914 (2020).","journal-title":"Respir. Med."},{"key":"40213_CR27","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.anai.2022.02.010","volume":"128","author":"OL Ramey","year":"2022","unstructured":"Ramey, O. L., Silva Almod\u00f3var, A. & Nahata, M. C. Medication adherence in Medicare-enrolled older adults with asthma before and during the coronavirus disease 2019 pandemic. Ann. Allergy Asthma Immunol. 128, 561-567.e1 (2022).","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"Suppl 1","key":"40213_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1590\/1806-9282.67.Suppl1.20201095","volume":"67","author":"M Y\u0131ld\u0131z","year":"2021","unstructured":"Y\u0131ld\u0131z, M., Aksu, F., Y\u0131ld\u0131z, N. & Aksu, K. Clinician\u2019s perspective regarding medication adherence in patients with obstructive lung diseases and the impact of COVID-19. Rev. Assoc. Med. Bras. 67(Suppl 1), 97\u2013101. https:\/\/doi.org\/10.1590\/1806-9282.67.Suppl1.20201095 (2021).","journal-title":"Rev. Assoc. Med. Bras."},{"issue":"8","key":"40213_CR29","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.clinthera.2017.06.010","volume":"39","author":"A L\u00f3pez-Vi\u00f1a","year":"2017","unstructured":"L\u00f3pez-Vi\u00f1a, A. et al. Multidisciplinary consensus on the nonadherence to clinical management of inhaled therapy in Spanish asthma patients. Clin. Ther. 39(8), 1730\u20131745 (2017).","journal-title":"Clin. Ther."},{"issue":"4","key":"40213_CR30","volume":"4","author":"R Normansell","year":"2017","unstructured":"Normansell, R., Kew, K. M. & Stovold, E. Interventions to improve adherence to inhaled steroids for asthma. Cochrane Database Syst. Rev. 4(4), CD012226 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"40213_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/MCP.0b013e32835b117a","volume":"19","author":"K Sumino","year":"2013","unstructured":"Sumino, K. & Cabana, M. D. Medication adherence in asthma patients. Curr. Opin. Pulm. Med. 19(1), 49\u201353 (2013).","journal-title":"Curr. Opin. Pulm. Med."},{"key":"40213_CR32","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1183\/09031936.00172114","volume":"45","author":"AL Dima","year":"2015","unstructured":"Dima, A. L. et al. Asthma inhaler adherence determinants in adults: Systematic review of observational data. Eur. Respir. J. 45, 994\u20131018 (2015).","journal-title":"Eur. Respir. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40213-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40213-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40213-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T21:37:39Z","timestamp":1700257059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40213-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["40213"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-40213-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"assertion":[{"value":"28 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JCLC has received speaker\u2019s and\/or consulting fees from Astra Zeneca, Almirall, Bial, Boehringer-Ingelheim, Chiesi, Esteve, Ferrer, GSK, Lilly, Menarini, Mundipharma, MSD, Novartis, Novo, Rovi, Teva, Viatris and Zamb\u00f3n. MP has received speaker\u2019s and\/or consulting fees from Astra Zeneca, GSK, Teva, Mylan, Bial, Novartis, Boehringer-Ingelheim and Pfizer. MS has received speaker\u2019s and\/or consulting fees from GSK, Teva, and Boehringer-Ingelheim. MEC has received consulting fees from Teva. These authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The rest of authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13086"}}